These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29393997)

  • 1. A multicentre integration of a computer-led follow-up of prostate cancer is valid and safe.
    Salem HA; Caddeo G; McFarlane J; Patel K; Cochrane L; Soria D; Henley M; Lund J
    BJU Int; 2018 Sep; 122(3):418-426. PubMed ID: 29393997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British urological surgery practice: 1. Prostate cancer.
    Savage P; Bates C; Abel P; Waxman J
    Br J Urol; 1997 May; 79(5):749-54; discussion 754-5. PubMed ID: 9158514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
    Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
    PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of consultant decision-making in the management of prostate cancer.
    Wilson J; Kennedy K; Ewings P; Macdonagh R
    Prostate Cancer Prostatic Dis; 2008; 11(3):288-93. PubMed ID: 17968424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views of health professionals on the role of primary care in the follow-up of men with prostate cancer.
    Watson EK; O'Brien R; Campbell C; Weller D; Neal RD; Wilkinson C; Rose PW;
    Fam Pract; 2011 Dec; 28(6):647-54. PubMed ID: 21693683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom.
    Donovan JL; Frankel SJ; Faulkner A; Selley S; Gillatt D; Hamdy FC
    BMJ; 1999 Jan; 318(7179):299-300. PubMed ID: 9924055
    [No Abstract]   [Full Text] [Related]  

  • 9. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer follow-up needs: do patients and professionals agree?
    Vieira I; Burke L; Marks-Maran D
    Br J Nurs; 2014 May 8-21; 23(9):S12, S14-9. PubMed ID: 24820509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hybrid hierarchical decision support system for cardiac surgical intensive care patients. Part II. Clinical implementation and evaluation.
    Ross JJ; Denaï MA; Mahfouf M
    Artif Intell Med; 2009 Jan; 45(1):53-62. PubMed ID: 19112011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists.
    Penson D; Moul J; Gandhi S; Newling D
    Urology; 2006 Jul; 68(1):80-4. PubMed ID: 16777198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.
    Spahn M; Morlacco A; Boxler S; Joniau S; Briganti A; Montorsi F; Gontero P; Bader P; Frohneberg D; van Poppel H; Karnes RJ;
    BJU Int; 2017 Nov; 120(5B):E52-E58. PubMed ID: 28220605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.
    Morgia G; Russo GI; Tubaro A; Bortolus R; Randone D; Gabriele P; Trippa F; Zattoni F; Porena M; Mirone V; Serni S; Del Nero A; Lay G; Ricardi U; Rocco F; Terrone C; Pagliarulo A; Ludovico G; Vespasiani G; Brausi M; Simeone C; Novella G; Carmignani G; Leonardi R; Pinnarò P; De Paula U; Corvò R; Tenaglia R; Siracusano S; Mantini G; Gontero P; Savoca G; Ficarra V;
    BJU Int; 2016 Jun; 117(6):867-73. PubMed ID: 26332130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision support systems in clinical practice: The case of venous thromboembolism prevention.
    Nazarenko GI; Kleymenova EB; Payushik SA; Otdelenov VA; Sychev DA; Yashina LP
    Int J Risk Saf Med; 2015; 27 Suppl 1():S104-5. PubMed ID: 26639683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].
    Heine K; Wolff JM
    Urologe A; 2005 Sep; 44(9):1009-12, 1014-7. PubMed ID: 16096743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.